This public procurement record has 4 releases in its history.

PlanningUpdate

03 Nov 2026 at 15:05

Planning

03 Nov 2026 at 13:57

PlanningUpdate

14 Jul 2026 at 17:42

Planning

12 Mar 2026 at 15:56

Summary of the contracting process

NHS England plans a national framework agreement for supplies of macitentan and cladribine tablets, pharmaceutical products for use across NHS services. The framework is split between the two medicines and into regional lots, covering delivery across England. NHS England is the buyer. The procurement is intended to cover suppliers planning to launch either of the medicines included. It is therefore relevant to pharmaceutical manufacturers and suppliers with, or developing, these tablet products and the ability to supply NHS demand across the relevant regions. The planned arrangement is a framework rather than a single one-off purchase, with supply organised by medicine and geography.

This is at the planning stage: NHS England has set out its intention to procure, but has not issued an invitation to tender. It expects to use an open procedure for a framework agreement. The estimated value is £128.4 million excluding VAT (£154.08 million including VAT). The framework is planned to start on 1 October 2027; lot periods range from 12 to 24 months, with options to extend by up to 24 months. NHS England expects to publish the next procurement notice on 4 December 2026. It is seeking preliminary market engagement through a supplier survey, with interest to be registered by 17 November 2026. The available planning information does not set out evaluation criteria or detailed eligibility requirements.

This is most relevant to suppliers that are developing or preparing to launch macitentan or cladribine tablets and can participate in NHS supply arrangements. NHS England specifically seeks engagement with current or potential new suppliers planning to launch either medicine, so manufacturers approaching launch may help inform the procurement before it reaches the market. The planned regional lots create scope for suppliers whose distribution and supply capacity is focused on particular parts of England, as well as those able to supply more widely. The framework’s scale and multi-year structure may suit businesses able to sustain supply over the relevant period and accommodate possible extensions. Small and medium-sized businesses are identified as suitable for the planned lot.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework Agreement for Macitentan & Cladribine Tablets

Notice Description

Project title: NHS National Framework Agreement for Macitentan & Cladribine Tablets Offer reference number: CM/TNS/26/5748 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5748/01 Macitentan Lot 1 DCE/DLN: 01/10/2027 to 30/09/2029 (24 months) CELN Lot 2 DNW/DLS: 01/10/2027 to 31/01/2029 (16 months) NWLS Lot 3 DNE/DSW: 01/10/2027 to 30/09/2029 (24 months) NESW CM/TNS/26/5748/02 Cladribine Tablets Lot 1 DCE/DSW: 01/10/2027 to 30/09/2029 (24 months) CESW Lot 2 DLN/DNW: 01/10/2027 to 31/01/2029 (16 months) NWLN Lot 3 DLS/DNE: 01/10/2027 to 30/09/2028 (12 months) LSNE Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Planning Information

NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to participate in a preliminary market engagement survey. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0668c2
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/104326-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£128,400,000 £100M-£1B
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
3 Nov 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
27 Jan 20273 months to go
Award Date
Not specified
Contract Period
1 Oct 2027 - 30 Sep 2029 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)

Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...